BRAINSTORM CELL THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2011 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of February 7th, 2011, by and between BrainStorm Cell Therapeutics, Inc., a Delaware corporation (the “Company”), and Karinel Ltd. (the “Purchaser”).
Issue Date: February 22, 2011 Shares of Common Stock (subject to adjustment as provided herein)Common Stock Purchase Warrant • March 31st, 2011 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED OTHER THAN IN COMPLIANCE WITH REGULATION S, PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION.
